亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations

生物 端粒 癌症 癌症的体细胞进化 遗传学 种系突变 生殖系 体细胞 突变 癌症研究 基因
作者
Fernanda Gutierrez‐Rodrigues,Emma M. Groarke,Natthakan Thongon,Juan Jose Rodriguez-Sevilla,Luiz Fernando Bazzo Catto,Marena R. Niewisch,Ruba Shalhoub,Lisa J. McReynolds,Diego V. Clé,Bhavisha A. Patel,Xiaoyang Ma,Dalton Hironaka,Flávia S. Donaires,Nina Spitofsky,Bárbara A. Santana,Tsung‐Po Lai,Lemlem Alemu,Sachiko Kajigaya,Ivana Darden,Weiyin Zhou
出处
期刊:Blood [Elsevier BV]
卷期号:144 (23): 2402-2416 被引量:4
标识
DOI:10.1182/blood.2024025023
摘要

Telomere biology disorders (TBD), caused by pathogenic germline variants in telomere-related genes, present with multi-organ disease and a predisposition to cancer. Clonal hematopoiesis (CH) as a marker of cancer development and survival in TBD is poorly understood. Here, we characterized the clonal landscape of a large cohort of 207 TBD patients with a broad range of age and phenotype. CH occurred predominantly in symptomatic patients and in signature genes typically associated with cancers: PPM1D, POT1, TERT promoter (TERTp), U2AF1S34, and/or TP53. Chromosome 1q gain (Chr1q+) was the commonest karyotypic abnormality. Clinically, multiorgan involvement and CH in TERTp, TP53, and splicing factor genes associated with poorer overall survival. Chr1q+, and splicing factor or TP53 mutations significantly increased the risk of hematologic malignancies, regardless of the clonal burden. Chr1q+ and U2AF1S34 mutated clones were pre-malignant events associated with the secondary acquisition of mutations in genes related to hematologic malignancies. Like known effects of Chr1q+ and TP53-CH, functional studies demonstrated that U2AF1S34 mutations primarily compensated for aberrant upregulation of TP53 and interferon pathways in telomere-dysfunctional hematopoietic stem cells, highlighting the TP53 pathway as a canonical route of malignancy in TBD. In contrast, somatic POT1/PPM1D/TERTp-CH had distinct trajectories unrelated to cancer development. With implications beyond TBD, our data show that telomere dysfunction is a strong selective pressure for CH. In TBD, CH is a poor prognostic marker associated with worse overall survival. The identification of key regulatory pathways that drive clonal transformation in TBD allows the identification of patients at a higher risk of cancer development.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
11秒前
徐悦月发布了新的文献求助10
12秒前
王志鹏发布了新的文献求助10
16秒前
17秒前
青木香发布了新的文献求助10
21秒前
怡然的绮烟完成签到 ,获得积分10
30秒前
青木香完成签到,获得积分10
30秒前
Hello应助怡然的绮烟采纳,获得10
47秒前
59秒前
nolan完成签到 ,获得积分10
1分钟前
小蘑菇应助科研通管家采纳,获得10
1分钟前
kk完成签到 ,获得积分10
1分钟前
1分钟前
Elvira完成签到,获得积分10
1分钟前
先玩了玉发布了新的文献求助10
1分钟前
笨笨完成签到,获得积分10
1分钟前
vchen0621完成签到,获得积分0
1分钟前
certe完成签到,获得积分10
1分钟前
1分钟前
vchen0621发布了新的文献求助10
1分钟前
先玩了玉完成签到,获得积分10
1分钟前
俞无声完成签到 ,获得积分10
1分钟前
花凉发布了新的文献求助20
2分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
研友_VZG7GZ应助科研通管家采纳,获得10
3分钟前
3分钟前
尊敬夜南完成签到,获得积分10
3分钟前
Cathy完成签到 ,获得积分10
3分钟前
今天看文献了吗完成签到,获得积分10
3分钟前
张晓祁完成签到,获得积分10
4分钟前
yueying完成签到,获得积分10
4分钟前
4分钟前
Owen应助尊敬夜南采纳,获得10
4分钟前
花凉完成签到,获得积分10
4分钟前
花凉发布了新的文献求助20
4分钟前
Ava完成签到,获得积分10
4分钟前
liudy完成签到,获得积分10
5分钟前
Ava发布了新的文献求助50
5分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990031
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256334
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805146
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228